Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Cafarotti

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Allergy and Clinical Immunology|July 28, 2021
Biologics as treatment options for anaphylaxisArianna Cafarotti, Alessandro Fiocchi, Stefania Arasi
Current Opinion in Allergy and Clinical Immunology|March 10, 2022
Cow's milk allergyStefania Arasi, Arianna Cafarotti, Alessandro Fiocchi
Current Opinion in Allergy and Clinical Immunology|April 17, 2026
Biologics in IgE-mediated food allergy: where are we know?Lucia Lo Scalzo, Arianna Cafarotti, Stefania Arasi
Current Opinion in Allergy and Clinical Immunology|March 26, 2021
Omalizumab as monotherapy for food allergyStefania Arasi, Maurizio Mennini, Arianna Cafarotti, et al.
Current Opinion in Allergy and Clinical Immunology|April 24, 2024
Perspectives in the validation of DEFASE: a paradigm shift in food allergy managementStefania Arasi, Carmen Mazzuca, Sara Urbani, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluationGiulio Dinardo, Arianna Cafarotti, Francesca Galletta, et al.
Current Opinion in Allergy and Clinical Immunology|May 15, 2023
Biologicals in IgE-mediated food allergyAntonio Mutarelli, Bruna Giavina-Bianchi, Stefania Arasi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 6, 2022
Management of IgE-mediated food allergy in the 21st centuryArianna Cafarotti, Mattia Giovannini, Philippe Begìn, et al.
Allergy|January 20, 2026
Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food Allergy: OSAFA Observational StudyStefania Arasi, Carol Bitetti, Lucia Lo Scalzo, et al.
The World Allergy Organization Journal|May 4, 2026
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomesLucia Lo Scalzo, Francesca Galletta, Arianna Cafarotti, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Allergy and Clinical Immunology|July 28, 2021
Biologics as treatment options for anaphylaxisArianna Cafarotti, Alessandro Fiocchi, Stefania Arasi
Current Opinion in Allergy and Clinical Immunology|March 10, 2022
Cow's milk allergyStefania Arasi, Arianna Cafarotti, Alessandro Fiocchi
Current Opinion in Allergy and Clinical Immunology|April 17, 2026
Biologics in IgE-mediated food allergy: where are we know?Lucia Lo Scalzo, Arianna Cafarotti, Stefania Arasi
Current Opinion in Allergy and Clinical Immunology|March 26, 2021
Omalizumab as monotherapy for food allergyStefania Arasi, Maurizio Mennini, Arianna Cafarotti, et al.
Current Opinion in Allergy and Clinical Immunology|April 24, 2024
Perspectives in the validation of DEFASE: a paradigm shift in food allergy managementStefania Arasi, Carmen Mazzuca, Sara Urbani, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluationGiulio Dinardo, Arianna Cafarotti, Francesca Galletta, et al.
Current Opinion in Allergy and Clinical Immunology|May 15, 2023
Biologicals in IgE-mediated food allergyAntonio Mutarelli, Bruna Giavina-Bianchi, Stefania Arasi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 6, 2022
Management of IgE-mediated food allergy in the 21st centuryArianna Cafarotti, Mattia Giovannini, Philippe Begìn, et al.
Allergy|January 20, 2026
Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food Allergy: OSAFA Observational StudyStefania Arasi, Carol Bitetti, Lucia Lo Scalzo, et al.
The World Allergy Organization Journal|May 4, 2026
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomesLucia Lo Scalzo, Francesca Galletta, Arianna Cafarotti, et al.
Pageof 2